Not Tagged
Not Tagged
[]
 jason, with higher response rate, i'm guessing it won't be long before this becomes the favored regimen for neoadjuvant use as well (probably somewhere by monday?). also appears to be some trade-off of diarrhea/nausea and less neuropathy. #gi23 
Physician-Scientist/Clinical Cancer Biologist. Clinical focus: GI Cancers/Neuro-Oncology. In lab: #TunnelingNanotubes and other drivers of La ChemoResistance